Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Major Depressive Disorder and Kappa Opioid Receptor
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Methylnaltrexone Mechanisms of Action and Effects on Opioid Bowel Dysfunction and Other Opioid Adverse Effects - Chun-Su Yuan, 2007
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
PDF) Opioids in COVID-19: Two Sides of a Coin
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
PDF) Major Depressive Disorder and Kappa Opioid Receptor Antagonists
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Major Depressive Disorder and Kappa Opioid Receptor
Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Frontiers | Opioids in COVID-19: Two Sides of a Coin
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
